• TechCrunch
• CrunchBase
• More
  • TechCrunch UK
  • TechCrunch France
  • TechCrunch Japan

Abingworth

edit

Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. We invest across all stages of company development including early and late-stage venture financing, growth equity and public companies.

Founded in 1973, Abingworth has a lengthy track record of building market leading companies. Our specialist team of over 20 professionals has a broad range of skills, including scientific and business expertise as well as investment banking, recruitment and legal knowledge. These resources are made available to portfolio companies. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston.

Milestones

edit

• 
  Abingworth invested in Prosensa. (1/25/12)
  Posted 1/25/12 at 4:05am via reuters.com
• 
  Abingworth invested in Valeritas. (9/12/11)
  Posted 9/12/11 at 5:48pm via finsmes.com
• 
  Abingworth invested in MD On-Line. (5/18/11)
  Posted 5/20/11 at 5:32pm via mdon-line.com
• 
  Abingworth invested in Syntaxin. (11/11/10)
  Posted 11/11/10 at 6:27pm via fiercebiotech.com
• 
  Abingworth invested in Pathwork Diagnostics. (10/6/10)
  Posted 10/7/10 at 9:23pm via dowjones.com
• 
  Abingworth invested in IS Pharma. (10/7/10)
  Posted 10/7/10 at 6:04pm via dowjones.com
• 
  Abingworth invested in Syntaxin. (11/14/05)
  Posted 7/3/10 at 1:04am
• 
  Abingworth invested in Adiana. (8/25/05)
  Posted 7/2/10 at 3:16am via allbusiness.com
• 
  Abingworth invested in Chroma Therapeutics. (4/3/06)
  Posted 4/19/10 at 9:38pm via chromatherapeutics.com
• 
  Abingworth invested in Syntaxin. (10/31/07)
  Posted 3/11/10 at 7:39pm via syntaxin.com
• 
  Abingworth invested in Zogenix. (1/9/08)
  Posted 12/20/09 at 8:04pm via zogenix.com
• 
  Abingworth invested in Oxagen. (11/24/09)
  Posted 11/25/09 at 4:32am via fiercebiotech.com
• 
  Abingworth invested in PrimeraDx. (10/30/09)
  Posted 10/30/09 at 5:51pm via onbiovc.com
• 
  Abingworth invested in Zogenix. (10/5/09)
  Posted 9/24/09 at 2:04am via sec.gov
• 
  Abingworth invested in Synosia Therapeutics. (1/5/07)
  Posted 9/16/09 at 2:50am via venturebeat.com
• 
  Abingworth invested in Intellikine. (7/22/09)
  Posted 7/28/09 at 1:25pm via onbiovc.com

Investments

Videos

Sources

1. Prosensa Raises €23 Million in New Equity Financing Led by New Enterprise Associates (reuters.com) [edit]
2. Valeritas Raises $150m in Series C financing. (finsmes.com) [edit]
3. MD On-Line Announces Equity Investment from Abingworth (mdon-line.com) [edit]
4. VCs inject $29M into Syntaxin, $11.5M into Ceregene (fiercebiotech.com) [edit]
5. Public IS Pharma Takes In $5.7M From Abingworth In Private Placement (fis.dowjones.com) [edit]
6. Alta Partners Leads $30M Series C For Pathwork Diagnostics (fis.dowjones.com) [edit]
7. Oxagen rounds up $26.7M in VC (fiercebiotech.com) [edit]
8. PrimeraDx, Inc.: Series C $20M (onbiovc.com) [edit]
9. SEC D (sec.gov) [edit]
10. Intellikine, Inc.: Series B $51M (onbiovc.com) [edit]
11. Capital Report Index [edit]
12. Clovis Oncology (Boulder, CO) an entity focused on licensing or acquiring rights to oncology compounds in all stages of clinical development (onbiovc.com) [edit]
13. Synosia raises $29M for Phase II testing (fiercebiotech.com) [edit]
14. Zogenix Raises $18 Million in Preferred Stock Financing (zogenix.com) [edit]
15. Syntaxin Raises $32M to Advance Development of Novel Drug Pipeline (syntaxin.com) [edit]
16. Neurological co. Synosis raises $32.5M (deals.venturebeat.com) [edit]
17. CHROMA THERAPEUTICS COMPLETES $53 MILLION SERIES C FINANCING (chromatherapeutics.com) [edit]
18. Cap Funding Report [edit]
19. Adiana, Inc. Reports Completion of $23 Million Financing. (allbusiness.com) [edit]
20. Broncus Technologies lines up venture debt financing for emphysema treatment (venturebeat.com) [edit]